4.5 Article

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

Journal

GENOME BIOLOGY
Volume 24, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13059-023-02881-5

Keywords

SARS-CoV-2; Evolution; Selection; Spike protein; Polymerase; NSP12; COVID-19; P323L

Ask authors/readers for more resources

The mutational landscape of SARS-CoV-2 varies between the dominant viral genome sequence and minor genomic variant population. The emergence of D614G substitution in the spike protein is associated with increased transmissibility. The P323L substitution in the viral polymerase is also observed, but not under strong selective pressure.
BackgroundThe mutational landscape of SARS-CoV-2 varies at the dominant viral genome sequence and minor genomic variant population. During the COVID-19 pandemic, an early substitution in the genome was the D614G change in the spike protein, associated with an increase in transmissibility. Genomes with D614G are accompanied by a P323L substitution in the viral polymerase (NSP12). However, P323L is not thought to be under strong selective pressure.ResultsInvestigation of P323L/D614G substitutions in the population shows rapid emergence during the containment phase and early surge phase during the first wave. These substitutions emerge from minor genomic variants which become dominant viral genome sequence. This is investigated in vivo and in vitro using SARS-CoV-2 with P323 and D614 in the dominant genome sequence and L323 and G614 in the minor variant population. During infection, there is rapid selection of L323 into the dominant viral genome sequence but not G614. Reverse genetics is used to create two viruses (either P323 or L323) with the same genetic background. L323 shows greater abundance of viral RNA and proteins and a smaller plaque morphology than P323.ConclusionsThese data suggest that P323L is an important contribution in the emergence of variants with transmission advantages. Sequence analysis of viral populations suggests it may be possible to predict the emergence of a new variant based on tracking the frequency of minor variant genomes. The ability to predict an emerging variant of SARS-CoV-2 in the global landscape may aid in the evaluation of medical countermeasures and non-pharmaceutical interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available